Literature DB >> 31788283

Spontaneous subgaleal hematoma in a patient with sickle cell disease: A case report and literature review.

Mohammed S Foula1, Ali Hassan2, Ahmed AlQurashi1, Amna Alsaihati2, Mohammed Sharroufna1.   

Abstract

Sickle cell disease (SCD) is a common hemoglobin disorder with variable clinical manifestations. Spontaneous subgaleal hematoma is rare, with sporadic cases reported in patients with SCD. Most cases resolve with conservative measures. Skull bone infarction should be considered a possible cause of severe acute headache in patients with SCD.
© 2019 King Fahd Hospital of the University. Clinical Case Reports published by John Wiley & Sons Ltd.

Entities:  

Keywords:  headache; sickle cell disease; skull bone infarction; subgaleal hematoma

Year:  2019        PMID: 31788283      PMCID: PMC6878059          DOI: 10.1002/ccr3.2435

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


INTRODUCTION

Sickle cell disease (SCD) is a genetic hemoglobin disorder characterized by sickling of red blood cells under hypoxic conditions. SCD is the most common hemoglobinopathy, with high prevalence in areas of the Mediterranean region, Africa, South America, and East Asia.1 Its clinical manifestations are variable and can include chronic hemolytic anemia, vaso‐occlusive crises (eg, pain syndromes, stroke and bone infarction), and organ dysfunction. Subgaleal hematomas can be classified into traumatic and non‐traumatic hematoma. In SCD, spontaneous subgaleal hematoma is a very rare complication of unclear pathophysiology, with few cases reported in the literature.2, 3 We report a case of a young patient with SCD presented with a headache and painful scalp swelling due to subgaleal hematoma.

CASE DESCRIPTION

A 15‐year‐old male patient known to have SCD (HbSS) presented to the emergency department complaining of a 4‐day history of persistent headache and two painful scalp swellings. The headache was constant with fluctuating intensity and was not relieved by simple analgesia. He denied any history of similar attacks nor trauma. He had been taking hydroxyurea and folic acid for the management of SCD. His past medical history included multiple vaso‐occlusive crises and a stroke with no residual neurological deficits. Upon examination, he appeared pale, in pain, and had an icteric tinge. He was febrile (37.9°C), tachycardic (105 beats/min), and had a consistent blood pressure (105/65 mm Hg). His oxygen saturation was 99% on room air. The two scalp swellings, involving the right parietal and left occipital regions, were tender and fluctuant with normal overlying skin. The rest of the examination was unremarkable. His laboratory results revealed a hemoglobin level of 9.3 g/dL, a hematocrit of 26% with a reticulocyte count of 7.4%, a white blood cell count of 13.6 × 106/µL with a left shift (75.5%, neutrophils), and a platelet count of 415 × 106/µL. Hemoglobin electrophoresis revealed an HbS of 81.1%. His liver function tests showed indirect hyperbilirubinemia (serum total bilirubin, 2.7 mg/dL; conjugated bilirubin, 0.3 mg/dL), while his renal function test results and coagulation profile were unremarkable. He was provisionally diagnosed as scalp hematoma with possible secondary infection and abscess formation. He was admitted for further investigations and management. He was commenced on intravenous hydration, morphine infusion, and regular lornoxicam for pain control. He was also empirically commenced on amoxicillin‐clavulanate. A computed tomography scan (CT) of his head revealed skull bone infarction at the right parietal and left occipital regions, with increased bone thickness. Additionally, two subgaleal fluid collections were observed in the same regions, measuring 8 and 7 mm at their maximum dimensions, respectively, without evidence of intracranial extension (Figure 1). Atrophy of the right hemisphere at the fronto‐temporo‐parietal lobes with dilatation of the ipsilateral ventricle was observed, which was consistent with the previous ischemic insults. We planned to continue on conservative management.
Figure 1

Non‐enhanced head CT; coronal (A) and axial (C) images showing: the right high parietal (asterix in A), left occipitoparietal (asterix in B) subgaleal collection and the considerable increase in cortical bone thickness

Non‐enhanced head CT; coronal (A) and axial (C) images showing: the right high parietal (asterix in A), left occipitoparietal (asterix in B) subgaleal collection and the considerable increase in cortical bone thickness His headache gradually improved with nonsteroidal anti‐inflammatory drugs and opioids. However, 2 days later, he started to develop right periorbital swelling associated with blurred vision. His ophthalmological evaluation showed no restriction of extraocular movements and intact pupillary reflexes. As orbital involvement was possible, he was kept under close observation. Over the next few days, no progression was noted, with gradual resolution of his symptoms. Therefore, the patient was discharged after 5 days. At follow‐up 2 weeks after discharge, he was asymptomatic with complete resolution of his scalp swellings.

DISCUSSION

Sickle cell disease is an autosomal recessive hemoglobin disorder resulting from the substitution of glutamic acid by valine at the sixth position of the beta‐globin gene, which leads to sickling of red blood cells in response to hypoxic conditions 4. SCD is the most common hemoglobinopathy in Saudi Arabia, with variable prevalence across the country reaching up to 2.6% in the Eastern Province.5 Pain is the hallmark and prominent cause of morbidity in patients with SCD. Frequent attacks of headache are common in children and adolescents, with an estimated prevalence of 24%‐43.9%.6 Acute attacks represent a diagnostic dilemma, with multiple differential diagnoses including severe anemia, stroke, effect of opioids, vascular diseases, bone infarction, osteomyelitis, and intracranial or extracranial bleeding.6 Extracranial bleeding may occur in different layers of the scalp. In neonates, different scalp hematomas may be frequently seen, especially after instrumental deliveries, including caput succedaneum and cephalohematoma.7 Subgaleal hematoma, defined as collection of blood below the galea aponeurotica layer, can be classified into traumatic and non‐traumatic according to its mechanism. Traumatic subgaleal hematoma can be caused by minor head trauma such as hair pulling,8 whereas non‐traumatic cases occur because of coagulopathies or rupture of superficial temporal artery aneurysms or arterio‐venous fistulas.9 Anatomically, the subgaleal space is located between the skull bones’ periosteum and the galea aponeurotica, extending anteriorly to the orbital ridges, posteriorly to the nuchal ridge, and laterally to the temporal fascia. It contains loose connective tissue and small emissary vessels connecting the extracranial venous system and the intracranial venous sinuses. Subgaleal hematoma results from the disruption of these emissary veins.10 Spontaneous subgaleal hematoma is very rare in SCD and is often accompanied by epidural hematoma.11 Subgaleal hematoma usually resolves spontaneously with conservative management. However, it may necessitate surgical evacuation if it persists.9 The pathophysiology of spontaneous subgaleal hematoma in patients with SCD is not clearly understood, with different presumed explanations in the literature. The common explanation is the development of subgaleal hematoma as a result of cortical bone disruption secondary to periosteal elevation after bone infarction. This theory can also explain its common association with epidural hematoma. Spontaneous rupture of vessels adjacent to the infarcted bone may represent an alternative mechanism.12, 13 Abnormal anatomy of skull bones secondary to chronic medullary hematopoiesis may cause rapid expansion of the bone marrow, particularly during acute episodes of anemia, precipitating the extravasation of blood into the subgaleal and epidural spaces.14 Additionally, impaired venous drainage could be the precipitating factor leading to excessive edema and, subsequently, hemorrhage.15 Skull bone infarction has been sporadically reported in SCD without accurate incidence. Bone infarction, usually seen in the long bones in SCD, results from a vaso‐occlusive crisis.4, 16 If the skull bones are involved, bone infarction commonly affects the orbital bones, mandible, and skull base.17, 18 When it occurs, skull bone infarction is also managed by conservative management, as the case of long bone infarction.4 Orbital involvement is scarce in such cases.19 It is caused by the accumulation of blood at the superior orbital ridges, which may disrupt the attachment of the arcus marginalis muscle, leading to blood accumulation within the orbital cavity, exophthalmos, decreased vision, and ophthalmoplegia.19, 20 A literature review using the search terms “sickle cell disease,” “subgaleal” “hematoma,” “spontaneous,” “skull bone infarction,” and “headache,” in the title, abstract, and/or keywords of articles indexed in the Medline, Scopus, and Google Scholar databases revealed only 12 cases of spontaneous subgaleal hematoma in patients with SCD in the English literature, seven of which were associated with epidural hematoma (Table 1).
Table 1

Reported cases of subgaleal hematoma and/or epidural hematoma in patients with sickle cell disease

No.YearAuthorAge (y)GenderHb defectScalp swellingSkull infarctionEpidural hematomaSubgaleal hematomaTherapy
11987Mallouh13MaleHbSSNoYesYesNoBilateral craniotomies
21991Karacostas19MaleHbSSNoYesYesNoSupportive care and dexamethasone
31995Tony35MaleHbS‐ThalassemiaNoYesYesNoSupportive care
41996Resar13MaleHbSSYesYesYesYesSupportive care
51996AlDabbous11MaleHbSSYesUnknownNoYesSupportive care
61996Pari25MaleHbSSYesYesNoYesSupportive care
71997Cabon14FemaleHbSSNoYesYesNoBilateral craniotomies
82000Naran16MaleHbSSYesYesYesNoSupportive care
92001Ganesh11MaleHbSSYesYesYesYesSupportive care
102004Okita2MaleHbSSNoUnknownYesNoCraniotomy
112004Okita12MaleHbSSNoYesYesNoSupportive care
122007Alli8MaleHbSSYesYesNoYesSupportive care
132009Dahdaleh18MaleHbSSYesNoYesYesBilateral craniotomies
142011Arends19MaleHbSCNoYesYesNoSupportive care
152011Sangle15MaleHbSSUnknownNoYesNoBilateral craniotomies
162012Babatola18MaleHbSSNoNoYesNoCraniotomy
172012Bölke19MaleUnknownUnknownNoYesNoCraniotomy
182012Patra13MaleUnknownUnknownNoYesNoBilateral craniotomies
192014Akodu12MaleHbSSYesUnknownUnknownUnknownSupportive care
202014Ilhan15MaleHbSSYesYesYesNoSupportive care
212014Page20MaleHbSSYesYesYesYesSupportive care
222014Page7FemaleHbSSUnknownYesYesNoCraniotomy
232014Serarslan19FemaleUnknownUnknownNoYesNoCraniotomy
242015Hettige7FemaleHbSSUnknownYesYesNoCraniotomy
252015Oka19MaleHbSCYesUnknownYesYesSupportive care
262016Boudreault17MaleHbSSYesUnknownNoYesSupportive care
272017Mishra18MaleUnknownYesNoYesYesCraniotomy
282017Saul18MaleHbSSNoYesYesNoUnknown
292018Gupta16MaleUnknownYesUnknownNoYesUnknown
302018Nelson13MaleHbSCYesYesYesYesCraniotomy
312019Boukassa10MaleHbSSNoUnknownYesNoCraniotomy
322019Boukassa16MaleHbSSNoNoYesNoCraniotomy
Reported cases of subgaleal hematoma and/or epidural hematoma in patients with sickle cell disease The current case had four main entities: headache, multiple subgaleal hematomas, skull bone infarction, and periorbital edema. There was no associated intracranial hemorrhage or exophthalmos, and the patient had mild, self‐limited visual symptoms. We proposed that a vaso‐occlusive crisis caused severe headache and skull bone infarction, which led to the subgaleal hematoma. The periorbital edema can be explained by the anterior extension of the subgaleal hematoma. Our decision to manage our patient conservatively was successful, with a gradual resolution of all symptoms. Spontaneous subgaleal hematoma is a rare clinical entity, with sporadic cases reported as a complication of SCD. Most cases resolve with conservative measures. However, this condition could be associated with life‐threatening intracranial hemorrhage. Skull bone infarction should be considered a possible cause of severe acute headache in patients with SCD.

CONFLICT OF INTEREST

The authors declare that they have no competing interests.

AUTHOR CONTRIBUTIONS

MF: writing the manuscript. AH: drafting the manuscript and reviewing the literature. AQ: editing the manuscript and reviewing the literature. AA: drafting the manuscript and reviewing the literature. MS: editing the manuscript and reviewing the literature.

CONSENT

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the consent is available for review by the Editor‐in‐chief of this journal on request.
  18 in total

1.  A case of non-traumatic subgaleal hematoma effectively treated with endovascular surgery.

Authors:  K Koizumi; S Suzuki; S Utsuki; K Nakahara; J Niki; I Mabuchi; A Kurata; K Fujii
Journal:  Interv Neuroradiol       Date:  2010-10-25       Impact factor: 1.610

2.  A Teenager With Sickle Cell Disease and Scalp Swelling.

Authors:  Courtney E Nelson; Richard J Scarfone
Journal:  Pediatr Emerg Care       Date:  2018-09       Impact factor: 1.454

Review 3.  Orbital involvement in sickle cell disease: a report of five cases and review literature.

Authors:  A Ganesh; R R William; S Mitra; S Yanamadala; S S Hussein; S Al-Kindi; M Zakariah; Z Al-Lamki; H Knox-Macaulay
Journal:  Eye (Lond)       Date:  2001-12       Impact factor: 3.775

4.  Acute soft head syndrome in children with sickle cell anaemia in lagos, Nigeria.

Authors:  Samuel Olufemi Akodu; Olisamedua Fidelis Njokanma; Ijeoma Nnenna Diaku-Akinwumi; Peter Odion Ubuane; Uchechukwu Okwudili Adediji
Journal:  Indian J Hematol Blood Transfus       Date:  2013-04-26       Impact factor: 0.900

5.  Severe unilateral headache caused by skull bone infarction with epidural haematoma in a patient with sickle cell disease.

Authors:  Samuel Arends; Jan Adriaan Coebergh; Jean Louis Kerkhoffs; Adrianus van Gils; Hille Koppen
Journal:  Cephalalgia       Date:  2011-07-29       Impact factor: 6.292

6.  Orbital infarction in sickle cell disease.

Authors:  Anuradha Ganesh; Sana Al-Zuhaibi; Anil Pathare; Ranjan William; Rana Al-Senawi; Abdullah Al-Mujaini; Samir Hussain; Yasser Wali; Salam Alkindi; Mathew Zachariah; Huxley Knox-Macaulay
Journal:  Am J Ophthalmol       Date:  2008-07-26       Impact factor: 5.258

Review 7.  A "neurosurgical crisis" of sickle cell disease.

Authors:  Nader S Dahdaleh; Timothy E Lindley; Patricia A Kirby; Hiroyuki Oya; Matthew A Howard
Journal:  J Neurosurg Pediatr       Date:  2009-12       Impact factor: 2.375

8.  Uncommon sites of bone infarction in a sickle cell anemia patient.

Authors:  I Garty; A Koren; E Katzumi
Journal:  Eur J Nucl Med       Date:  1983

9.  Facial bone infarcts in sickle cell syndromes.

Authors:  J E Royal; V J Harris; P K Sansi
Journal:  Radiology       Date:  1988-11       Impact factor: 11.105

Review 10.  Epidemiology of sickle cell disease in Saudi Arabia.

Authors:  Wasil Jastaniah
Journal:  Ann Saudi Med       Date:  2011 May-Jun       Impact factor: 1.526

View more
  1 in total

1.  Acute Soft Head Syndrome (Subgaleal Haematoma) with Periorbital Oedema as a Rare Presentation in Sickle Cell Disease.

Authors:  Rehab Y Al-Ansari; Maan Al Harbi; Nawaf Al-Jubair; Leena Abdalla
Journal:  Eur J Case Rep Intern Med       Date:  2020-07-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.